The greenhouse grower uses hydroponic technology to grow leafy greens and wants to make its produce accessible to more than half the US population by 2026.
Synthesis Capital – founded by two former VC investors at Jeremy Coller’s family office – has raised $300m for its debut alternative protein venture fund.
The vehcile attracted investment from a wide pool of LPs including sovereign wealth funds, pensions and family offices as it hit its $175m target within three months of launching in 2021.
The growth and agtech vehicles have received strong interest from North American institutional LPs, with LACERA having already committed $100m to the funds.
The round overtakes Future Meat’s $347m 2021 Series B as the biggest yet from the cultured meat industry and comes at a time of increasing momentum and interest.